This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement N° 871336  

Consortium partners

Philips

We are a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated sales of EUR 19.5 billion in 2019 and employs approximately 80,000 employees with sales and services in more than 100 countries.

At Philips, our vision is to strive to make the world healthier and more sustainable through innovation.

Our goal is to improve the lives of 3 billion people a year by 2030. We will be the best place to work for people who share our passion. Together, we will deliver superior value for our customers and shareholders.

Philips Research is a global organization that helps Philips introduce innovations that improve people’s lives. Philips Research provides technology options for innovations in the area of health and well-being, targeted at both developed and emerging markets. Positioned at the front-end of the innovation process, Philips Research works on everything from spotting trends and ideation to proof of concept and – where needed – first-of-a-kind product development. In addition, our open innovation approach enables us to consistently break new ground in the challenging healthcare domain. We do this by collaborating with many world-class partners and participate in public-private partnerships to expand and share knowledge, such as Horizon 2020.

Within PEROXIS, Philips will define X-ray system requirements for cardiovascular imaging and COPD imaging in WP1, including the objectives for conversion material layers as well as the specification for detectors and subcomponents. Also suitable detector architectures and designs of PEROXIS detector test vehicles and demonstrators will be proposed. In WP5 Philips will support the supply and pre-qualification of test vehicles and proto detectors for delivery to WP6. Philips will lead WP6 which integrates innovative perovskite-based detectors in X-ray systems and demonstrates imaging performance for cardiovascular and phase contrast imaging.

The latest news from PEROXIS